Stress granules (SGs) and processing bodies (PBs) are microscopically visible ribonucleoprotein granules that cooperatively regulate the translation and decay of messenger RNA 1-3 . Using an RNA-mediated interference-based screen, we identify 101 human genes required for SG assembly, 39 genes required for PB assembly, and 31 genes required for coordinate SG and PB assembly. Although 51 genes encode proteins involved in mRNA translation, splicing and transcription, most are not obviously associated with RNA metabolism. We find that several components of the hexosamine biosynthetic pathway, which reversibly modifies proteins with O-linked N-acetylglucosamine (O-GlcNAc) in response to stress, are required for SG and PB assembly. O-GlcNAc-modified proteins are prominent components of SGs but not PBs, and include RACK1 (receptor for activated C kinase 1), prohibitin-2, glyceraldehyde-3-phosphate dehydrogenase and numerous ribosomal proteins. Our results suggest that O-GlcNAc modification of the translational machinery is required for aggregation of untranslated messenger ribonucleoproteins into SGs. The lack of enzymes of the hexosamine biosynthetic pathway in budding yeast may contribute to differences between mammalian SGs and related yeast EGP (eIF4E, 4G and Pab1 containing) bodies.
; the stress-induced signalling pathways controlling PB assembly therefore remain unidentified. Conversely, clotrimazole and heat shock trigger SG assembly but not PB assembly 13 . For the systematic identification of proteins involved in SG and PB assembly, we devised a functional RNA-mediated interference (RNAi) screen for human genes involved in these processes. A human U2OS cell (RDG3) was established that stably expressed fluorescently tagged SG and PB markers (green fluorescent protein (GFP)-G3BP and red fluorescent protein (RFP)-DCP1a) 14 . Unstressed RDG3 cells contain PBs (in 30-50% of cells) but no SGs, similarly to parental U2OS cells 3 . Arsenite causes RFP-DCP1a to assemble into PBs and GFP-G3BP to assemble into SGs in about 90% of RDG3 cells ( Supplementary Information, Fig. S1a ). Timelapse microscopy reveals synchronous SG and PB assembly on treatment with arsenite (Supplementary Information, Video S1). siRNAs targeting known SG and PB constituents were used to inhibit the assembly of RNA granules ( Supplementary Information, Fig. S1b ). In accord with previous reports, siRNAs targeting heme regulated inhibitor (HRI) prevent the assembly of SGs but not PBs, whereas siRNAs targeting Rck (p54) strongly inhibit PB assembly, but SG assembly only weakly ( Supplementary  Information, Fig. S1b, c) . As reported previously 10, 15 , decreased expression of DCP2 or the 5´-3´ exonuclease XRN1 promotes PB assembly, a probable consequence of decreased mRNA decay ( Supplementary Information,  Fig. S1b ). Moreover, siRNAs targeting GW182, Lsm1 and Lsm4 significantly inhibit the assembly of PBs ( Supplementary Information, Fig. S1b ). For the screening assay, we used HRI and Rck as positive controls for SG and PB assembly, respectively. 2 These authors contributed equally to this work. 3 Correspondence should be addressed to P.A. (e-mail: panderson@rics.bwh.harvard.edu) l e t t e r s
We used this assay to screen the druggable genome (Dharmacon) targeting 7,317 genes with pools of four different siRNAs per gene ( Supplementary Information, Fig. S1f ). Pools scoring positive in the initial assay were subjected to a secondary screen with each of the four siRNAs individually. Genes that reduced SG and/or PB assembly when targeted by at least two independent siRNAs (Fig. 1a) are listed in Supplementary Information, Table S1 . Not surprisingly, transcription and translation factors make up 26.8% of the genes detected (Fig. 1b) . For example, knockdown of RNA polymerases or their regulatory subunits (for example BDP1; Fig. 1c ) prevents the assembly of both SGs and PBs. Strikingly, the individual knockdown of six different eIF3 subunits prevents SG assembly. This robust and SG-specific effect indicates that eIF3 is critical to SG assembly. Knockdown of nine ribosomal proteins prevents the assembly of both SGs and PBs (RLP10; Fig. 1c ; Supplementary Information, Table S1 ). The requirement for large ribosomal subunit proteins may be indirect, because large ribosomal subunits are excluded from SGs and PBs 6 . It is possible that decreased levels of specific large ribosomal proteins slow elongation or termination, thus impairing polysome disassembly and inhibiting the assembly of both SGs and PBs, as do elongation inhibitors such as emetine or cycloheximide 13, 16 . siRNA treatments from the primary screen alter the assembly of stress granules (green, GFP-G3BP) and P-bodies (red, RFP-DCP1a). SORT1, BDP1 and RPL10 knockdowns eliminate both SGs and PBs; RAB36 prevents PB assembly but not SG assembly, eIF3S2 knockdown prevents SG assembly but not PB assembly, and PRPF18 eliminates SG assembly but induces huge PBs. Genes that independently regulate the assembly of SG or PB include the Ras-related protein RAB36 (PB-specific) and the frizzled homologue FZD2 (SG-specific), whereas the glucose regulator SORT1 (sortilin) is required for the assembly of both SG and PB (Fig. 1c) . Knockdown of the cyclophilin-binding protein PRPF18 inhibits SGs and causes the assembly of giant PBs (Fig. 1c) Glc-6-P Fru-6-P GlcNH 2 -6-P GlcNAc-6-P Merge  DCP1  OGN  eIF3  Merge  DCP1  OGN  eIF3  Merge  DCP1  OGN  eIF3  Merge  DCP1  OGN  eIF3 No drug 500 µM arsenite 20 µM clotrimazole 50 µM pateamine A 10 µm 
l e t t e r s
Sortilin is a transmembrane protein regulating the vesicular trafficking of several proteins including the GLUT4 glucose transporter, whose translocation to the plasma membrane controls glucose uptake (Fig. 2a) 
17
. Intracellular glucose can be converted to glycogen for storage, metabolized to pyruvate by glycolysis, or converted to UDP-GlcNAc, a substrate of the hexosamine biosynthetic pathway (HBP) [18] [19] [20] [21] . The reversible O-GlcNAc modification of serine or threonine residues of myriad proteins constitutes an important glucose-sensing signalling pathway in metazoans [18] [19] [20] [21] . Moreover, arsenite promotes the O-GlcNAc modification of cellular proteins 22 , which confers protection against environmental and physiological stress [23] [24] [25] . O-GlcNAc modification is also activated during nutritional stress 26, 27 . We therefore targeted key HBP enzymes (Fig. 2a, red) , to determine whether O-GlcNAc modifications promote arsenite-induced SG or PB assembly. In cells treated with control siRNA (D0), arsenite increases the levels of O-GlcNAc-modified proteins (Fig. 2b, compare lanes 3 and 6) . Although knockdown of sortilin modestly increases the levels of constitutive O-GlcNAc-modified proteins, it strongly prevents their arsenite-induced increase (Fig. 2b, compare  lanes 1 and 4) . Knockdown of O-GlcNAc transferase (OGT) decreases constitutive levels of O-GlcNAc-modified proteins and prevents their stress-induced increase (Fig. 2b, compare lanes 2 and 5) . Neither sortilin knockdown nor OGT knockdown affects eIF2α phosphorylation, indicating that O-GlcNAc modifications act independently (Fig. 2b) .
We confirmed that sortilin knockdown inhibits arsenite-induced SG assembly (Fig. 2c) . OGT knockdown also inhibits SG assembly, whereas knockdown of MGEA5 (O-GlcNAcase, the enzyme that removes O-GlcNAc) had no effect. Knockdown of GFAT2 (glutamine:fructose-6-phosphate amidotransferase 2), but not GFAT1, enzymes that are required for the synthesis of UDP-GlcNAc, also inhibits SG assembly ( Fig. 2a, c; Supplementary Information, Fig. S2 ). Sortilin knockdown inhibits both constitutive and arsenite-induced PB assembly, whereas OGT and GFAT2 inhibit constitutive, but not arsenite-induced, PB assembly ( Fig. 2d) . We reassayed these genes in U2OS cells stained for endogenous SG markers and examined at different times, to verify that the knockdowns abolished SG assembly rather than merely delaying it ( Supplementary Information, Fig. S2 ). The results confirm that knockdowns of sortilin, OGT or GFAT2 impair SG assembly. Because high (overexpressed) or low (knockdown) expression of many SG or PB components regulates SG or PB nucleation These results suggest that OGT-mediated O-GlcNAc modifications may precede the recruitment of modified proteins to SGs, and that sortilin knockdown may act upstream of OGT to inhibit SG assembly. The effects of sortilin (but not OGT) knockdown on arsenite-induced PB assembly may indicate the involvement of additional factors or pathways.
To identify specific O-GlcNAc-modified proteins involved in SG assembly, we analysed sucrose gradient fractions obtained from control versus arsenite-treated U2OS cells (Fig. 3a) . Immunoblotting with two different anti-O-GlcNAc antibodies reveals the arsenite-induced O-GlcNAc modification of numerous low-molecular-mass (10-40-kDa) proteins that sediment together with monosomes and untranslated mRNPs (Fig. 3a , boxed regions). These fractions were precipitated with acetone, boiled in 1% SDS to disrupt protein or mRNP complexes completely, then diluted and immunoprecipitated with anti-O-GlcNAc antibodies (see Methods). O-GlcNAc-modified proteins resolved on PAGE were revealed by staining with colloidal blue (Fig. 3b) ; they were then excised and subjected to mass spectrometry, which identified small and large ribosomal subunit proteins (RPS3, 9, 11 and 24, and RPL6, 13a, 14, 30 and 36a-like), the ribosome-associated protein RACK1, the multifunctional proteins glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and prohibitin-2, and several other proteins (Supplementary Information, Table S2 ). GAPDH and RPS24 are known O-GlcNAc-modified proteins, thus validating our methodology 18, 30 . Sucrose gradient analysis indicates that RACK1 and prohibitin-2 move from polysome-containing fractions to monosomecontaining and ribosomal subunit-containing fractions on treatment with arsenite ( Supplementary Information, Fig. S4 ), suggesting that both proteins associate with the translational machinery. Immunostaining confirms that RACK1 and prohibitin-2 are present in arsenite-induced SGs Table S1 ), are also found to be O-GlcNAc-modified by this approach (Supplementary Information, Table S2 ). Previous studies indicate that RPL5 depletion does not affect global translation in U2OS cells, suggesting that inhibition of SG or PB assembly by RPL5 ablation is not due to impaired basal translation 31 . To confirm that these proteins are indeed O-GlcNAc-modified in response to arsenite, we labelled cells metabolically for 2 days with tetraacetylated N-azidoacetylglucosamine (GlcNAz) (Invitrogen Click-iT kit; see Methods). Untreated cells, labelled cells and labelled cells treated with arsenite were harvested in parallel and lysed, and total GlcNAzlabelled proteins were biotinylated with a chemoselective ligation reaction (Fig. 3c ). Biotinylated proteins were purified with streptavidinagarose beads, resolved by SDS-PAGE and blotted for OGT, a known O-GlcNAc-modified protein. As shown in Fig. 3d , OGT is present only in labelled cells (compare lanes 5 and 6 with lane 4). Treatment with arsenite increases the amount of bound OGT (compare lanes 5 and 6), indicating that OGT is O-GlcNAc-modified on treatment with arsenite 22 . We then probed for candidate O-GlcNAc-modified ribosomal proteins identified by O-GlcNAc immunoprecipitation and mass spectrometric analysis. RPS3 and RPL13a are clearly detected, and both show an arsenite-induced increase in signal, confirming that proteins from both small and large ribosomal subunits are O-GlcNAc-modified in response to arsenite. Model of SG versus PB assembly. Left: normal termination results in an mRNP that is eligible for deadenylation and eventual recruitment to the decapping and decay machinery of a PB. Right: stress-induced polysome disassembly caused by stalled initiation results in a 48S complex that is eligible for O-GlcNAc modification and SG assembly. Some mRNPs from SGs may be translocated to PBs, whereas others may be reinitiated or stored.
l e t t e r s
Arsenite-induced eIF2α phosphorylation causes translational arrest, polysome disassembly and SG assembly 2 . We used sucrose gradient analysis to determine the stage at which sortilin and OGT act. U2OS cells treated with control siRNAs (Fig. 4a) or with siRNAs targeting HRI (Fig. 4b), sortilin (Fig. 4c) or OGT (Fig. 4d) were untreated or arsenitetreated before sucrose gradient analysis. As expected, arsenite efficiently disassembles polysomes in control cells (D0) but not in HRI knockdown cells. In contrast, treatment with arsenite collapses polysomes in cells treated with siRNA targeting sortilin or OGT, indicating that O-GlcNAc modifications do not impair polysome disassembly but are required for 48S complexes to organize into SGs. Sortilin knockdown is significantly toxic, resulting in a lower signal (due to reduced cell number) and partly dismantled polysomes, but treatment with arsenite clearly enhances polysome disassembly (Fig. 4c, compare green and red tracings) . No toxicity is seen in OGT knockdowns (Fig. 4d) , which behaved identically to the control (Fig. 4a) . Because O-GlcNAc-modified ribosome-associated proteins are SG components, and because impaired O-GlcNAc modification prevents SG assembly, it seems that O-GlcNAc modifications of ribosomal subunits contribute to SG assembly downstream of polysome disassembly, probably at the aggregation stage.
Our results underscore the complexity of SG or PB assembly, and suggest a model to describe their interrelationship (Fig. 5 ). Both the assembly of SGs and that of PBs require polysome disassembly; however, the mode of polysome disassembly determines whether PBs or SGs assemble. Normally (Fig. 5, left pathway) , mRNAs targeted for decay are deadenylated, breaking the connection between the 5´ and 3´ ends of the polysomal mRNA. The resulting decreased initiation efficiency causes polysome disassembly, freeing the resulting mRNP for incorporation into a PB. Upon stress (Fig. 5 , right pathway), eIF2α phosphorylation causes stalled initiation, the assembly of a 48S mRNP, and polysome disassembly yielding circularized mRNPs, which are assembled into SGs in an eIF3-dependent manner. Polysome disassembly does not require O-GlcNAc addition, but O-GlcNAc modifications of the translation machinery (for example ribosomal protein subunits, RACK1 and prohibitin-2) promote the aggregation of 48S mRNPs into SGs. Because some mRNPs may transit through SGs to PBs 2 , the inhibition of SG assembly may secondarily affect PB assembly, thus explaining the modest effects of OGT on basal PB levels without stress.
Conditions that decrease O-GlcNAc modification decrease the expression of heat-shock protein 70 (Hsp70; ref. 22) . Because Hsp70 overexpression enhances SG disassembly 32 (or inhibits SG assembly 33 ), Hsp70 should not be a hit in our screen. Indeed, siRNA against Hsp70 was among those screened, but it did not prevent SG or PB assembly in our system. Finally, we note that glucose deprivation induces budding yeasts to form 'EGP bodies' containing some SG markers (eIF4E, eIF4G and Pab1), but lacking 40S subunits and eIF3 (refs 34, 35) . EGP bodies often form adjacent to P-bodies, similarly to the pairing of arsenite-induced mammalian SGs and PBs 13 . Budding yeasts lack OGT, HBP enzymes and some eIF3 subunits; O-GlcNAc modification of the translational machinery may therefore account for differences between yeast EGP bodies and mammalian stress granules. Indeed, O-GlcNAc modification of ribosomal subunits may regulate the assembly of other RNA granules containing ribosomal subunits, such as neuronal granules. The wide variety of genes detected in this screen provides increasing evidence that SG and PB assembly integrate many aspects of cellular metabolism with RNA translation and decay.
METHODS
Cell culture and drug treatment. U2OS (human osteosarcoma), COS7 and RDG3 cells were maintained in DMEM medium (Gibco) supplemented with 10% inactivated fetal bovine serum (Sigma), 1% (v/v) penicillin and streptomycin (Sigma) at 37 °C in 6% CO 2 . To induce SGs and PBs, cells were treated with sodium arsenite (either 0.1 mM or 0.5 mM) for between 30 min and 1 h. Clotrimazole was used at 20 µM in serum-free medium for 1 h. Pateamine A (Desmethyldesamino-modified; a gift from Jun Lui, Johns Hopkins University) was used at 50 µM for 1 h.
Establishment of RDG3 double stable cell line. Detailed procedures for making RDG3 double stable cells (SG marker, GFP-G3BP; PB marker, RFP-DCP1a) and for their selection and characterization are described elsewhere 14 .
Antibodies. All antibodies used in this study are listed in Supplementary Information, Table S3 .
RNAi library screen and hit validation. RDG3 double stable cells were freshly plated 24 h before being screened; 60% confluent RDG3 cells were trypsinized and resuspended in DMEM (15% FBS) at a concentration of 50 cells µl −1 . All siRNA transfections were performed in duplicate. In 384-well plates, 9 µl of lipid mix (Lipofectamine 2000 plus Opti-MEM; Invitrogen) and 1.5 µl of siRNA (1 µM, mixture of four different oligonucleotides; Dharmacon SMARTpool) were added and incubated for 30 min. Finally, 1,000 RDG3 cells were plated in each well and incubated for 72 h to induce gene silencing. To induce the assembly of SGs and PBs, sodium arsenite (0.5 mM final concentration) was added to the growth medium and cells were incubated for 30 min. Cells were fixed (4% paraformaldehyde in PBS, 15 min), permeabilized (ice-cold methanol, 5 min) and stained with Hoechst (Sigma) dye to reveal nuclei. In the secondary screen, the four different siRNAs targeting genes identified in the primary screen were randomly localized in 384-well plates, and the assay was repeated. Only genes that were detected when targeted by at least two independent siRNAs were judged as robust positives; these are summarized in Supplementary Information, Table S1 .
RNA interference and quantification of knockdown effect on SGs and PBs. U2OS or RDG3 cells were transfected with siRNAs at 40 nM final concentration using Lipofectamine 2000 (Invitrogen). After 40 h, cells were trypsinized, reseeded and transfected again for a further 40-44 h. For single transfection, cells were treated for 48-72 h and processed for the next step. Knockdown efficiencies were verified by either immunoblotting or real-time quantitative PCR with reverse transcription (RT-qPCR). siRNAs were purchased from Ambion or Dharmacon. Control siRNAs, D0 and U0, were described previously 36 . siRNA target sequences to deplete each protein used in this study are listed in Supplementary Information, Table S3 . Knockdown effects on SGs and PBs were assessed by quantifying the number of cells out of more than 100 cells from different fields.
Immunofluorescence microscopy. General immunofluorescence procedures were performed as described previously 3 . Cells grown on coverslips were rinsed with PBS (pH 7.4), fixed with 4% paraformaldehyde for 15 min, permeabilized with cold methanol for 10 min or with 0.5% Triton X-100 in PBS in some cases (as specified below) and blocked by incubation in 5% normal horse serum in PBS containing 0.02% sodium azide (NHS/PBS-A) for at least 1 h. Primary antibodies diluted in blocking solution were added and incubated for about 1 h at 22-24 °C. Cells were then washed twice with PBS. Finally, cells were incubated with secondary antibodies (Jackson Immunoresearch ML grade) for 1 h, washed with PBS (three times, 5-10 min each) and mounted in polyvinyl-based mounting medium. Wide-field fluorescence microscopy was performed with an Eclipse E800 (Nikon) equipped with epifluorescence optics and a digital camera (CCD-SPOT RT; Diagnostic Instruments). The images were compiled with Adobe Photoshop (v. 10).
Immunoblot analysis. Cell extracts were prepared with RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% Nonidet P40, 1% sodium deoxycholate, 0.1% SDS) or direct lysis buffer (5 mM MES, pH 6.5, 2% SDS) and proteins were quantified, where indicated, with bicinchoninic acid assay reagent (Pierce). Total proteins (5-10 µg) were subjected to 4-20% gradient PAGE in SDS, transferred to nitrocellulose membranes and probed with the indicated antibodies with PBS containing 5% normal horse serum as a blocking reagent.
l e t t e r s
Polysome profiling analysis. U2OS cells (4 × 10 6 ) cultured at 80-90% confluence were incubated with or without 0.1 mM sodium arsenite for 1 h before the addition of 10 µg ml −1 cycloheximide, washed with cold PBS, then scrape-harvested into 1 ml of polysome lysis buffer (15 mM Tris-HCl pH 7.4, 15 mM MgCl 2 , 0.3 M NaCl, 1% Triton X-100) supplemented with 0.1% (v/v) 2-mercaptoethanol, 100 µg ml −1 cycloheximide, 0.1 mg ml −1 heparin, protease inhibitor cocktail (EDTA-free; Pierce) and RNAsin (Ambion). After 15 min of tumbling in the cold room, nuclei were pelleted (10,000g for 10 min) and supernatants were fractionated in 10-50% linear sucrose gradients by ultracentrifugation (125,000g. for 3 h 10 min) in a Beckman ultracentrifuge and an SW40 Ti rotor. Gradients were eluted with a gradient fractionator (Brandel) and monitored with a UA-5 detector (ISCO). Fractions were acetone-precipitated, and processed for further analyses.
Immunopurification of O-GlcNAc-modified proteins. Extracts from cells treated for 45 min with 0.5 mM sodium arsenite were prepared from two 90% confluent 150-mm dishes and applied to sucrose gradients as described above. For immunopurification of low-molecular-mass (10-40 kDa) O-GlcNAc-modified proteins induced by arsenite treatment, fractions containing most of the O-GlcNAc-modified proteins from the polysome gradient (18 fractions in total) were pooled, precipitated with acetone (60% final concentration) overnight at −20 °C and centrifuged at 14,000g for 15 min. Air-dried pellets were resuspended in 0.12 ml of denaturing buffer (50 mM Tris-HCl pH 7.5, 2 mM EDTA, 1% SDS), boiled for 5 min, diluted with 1.08 ml of immunoprecipitation (IP) buffer (50 mM Tris-HCl pH 7.5, 2 mM EDTA, 150 mM NaCl, 0.1% Nonidet P40) containing protease inhibitor cocktail (Pierce). Denatured total proteins were incubated with anti-O-GlcNAc antibody (10 µg; ABR) for 1 h at 4 °C followed by incubation overnight with 20 µl of pre-equilibrated protein A/G beads (Pierce) at 4 °C. The bead pellet was washed five times with 1 ml of IP buffer, treated with SDS sample buffer (without reducing agent), and subjected to 14% SDS-PAGE. Colloidal blue stain (Invitrogen) was used to reveal proteins; these were excised from the gel and identified by mass spectrometric analysis (Taplin Biological Mass Spectrometry Facility at Harvard Medical School).
Metabolic labelling and detection of O-GlcNAc-modified proteins.
Metabolic labelling of O-GlcNAc-modified proteins was performed with Click-iT GlcNAz metabolic glycoprotein labelling reagent (Invitrogen). Labelled proteins were biotinylated (Click-iT protein analysis detection kit) and then purified by using streptavidinagarose beads (Invitrogen); final products were subjected to immunoblot analyses.
Quantitative real-time PCR. Total RNA samples were prepared with TRIzol (Invitrogen) and quantified by spectrophotometry. RNA (5 µg) was treated with DNAase followed by cDNA synthesis with i-script cDNA synthesis kit (Bio-Rad). RT-qPCR was performed based on the SYBRgreen method with SYBR mix (BioRad) in a cycler (MX3000p; Stratagene).
Live-cell imaging. Live-cell videos were taken on a Nikon TE2000-U inverted microscope equipped with a Nikon C1 Plus confocal system (BWH Confocal Core). Cells were maintained at 37 °C with 10% CO 2 in an incubated microscope enclosure. Z stacks were acquired with a large (100-µm) pinhole at 0.8 µm steps through the entire cells every minute, and were rendered into two-dimensional images.
Note: Supplementary Information is available on the Nature Cell Biology website.
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Histone Immunofluorescence microscopy. To detect endogenous sortilin, RACK1
(Santa Cruz Biotechnlogy, sc-17754), and O-GlcNAc using an IgM antibody (CTD110.6, Covance), cells were fixed with 4% paraformaldehyde and permeabilized with 0.5% Triton-X100 in PBS for 5 min. All other samples were stained using a slightly different fixation method (4% paraformaldehyde in PBS for Biotinylation of O-GlcNAc-modified proteins was performed using Click-iT™ protein analysis detection kit (C33372, Invitrogen). Cell lysates (200 µg) were subjected to Click-iT™ azide/alkyne reaction and final protein pellets were
